Sigma-2 receptors—From basic biology to therapeutic target: A focus on age-related degenerative diseases

BN Lizama, J Kahle, SM Catalano… - International journal of …, 2023 - mdpi.com
There is a large unmet medical need to develop disease-modifying treatment options for
individuals with age-related degenerative diseases of the central nervous system. The …

[HTML][HTML] Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases

DA Ryskamp, S Korban, V Zhemkov… - Frontiers in …, 2019 - frontiersin.org
Sigma-1 receptor (S1R) is a multi-functional, ligand-operated protein situated in
endoplasmic reticulum (ER) membranes and changes in its function and/or expression have …

[HTML][HTML] Sigma-1 and Sigma-2 receptor modulators as potential therapeutics for Alzheimer's disease

RB Kargbo - ACS Medicinal Chemistry Letters, 2021 - ACS Publications
Assignee Company. Northwestern University [US/US]; 633 Clerk Street, Evanston, Illinois
60208, United States Disease Area. Alzheimer, s disease Biological Target. SIGMA-1 and …

Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases

T Maurice, N Goguadze - Sigma Proteins: Evolution of the Concept of …, 2017 - Springer
Abstract The sigma-1 (σ 1) receptor has been associated with regulation of intracellular Ca
2+ homeostasis, several cellular signaling pathways, and inter-organelle communication, in …

Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection

L Nguyen, BP Lucke-Wold, S Mookerjee… - Sigma Receptors: Their …, 2017 - Springer
Sigma-1 receptors are molecular chaperones that may act as pathological mediators and
targets for novel therapeutic applications in neurodegenerative diseases. Accumulating …

[HTML][HTML] Roles of sigma-1 receptors in Alzheimer's disease

JL Jin, M Fang, YX Zhao, XY Liu - International journal of clinical …, 2015 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading
cause of senile dementia all over the world. Still no existing drugs can effectively reverse the …

[HTML][HTML] Role of sigma-1 receptors in neurodegenerative diseases

L Nguyen, BP Lucke-Wold, SA Mookerjee… - Journal of …, 2015 - Elsevier
Neurodegenerative diseases with distinct genetic etiologies and pathological phenotypes
appear to share common mechanisms of neuronal cellular dysfunction, including …

Emerging benefits: pathophysiological functions and target drugs of the sigma-1 receptor in neurodegenerative diseases

N Wu, Y Ye, B Wan, Y Yu, C Liu, Q Chen - Molecular Neurobiology, 2021 - Springer
Abstract The sigma-1 receptor (Sig-1R) is encoded by the SIGMAR1 gene and is a
nonopioid transmembrane receptor located in the mitochondrial-associated endoplasmic …

Sigma receptors as potential therapeutic targets for neuroprotection

L Nguyen, N Kaushal, MJ Robson… - European journal of …, 2014 - Elsevier
Sigma receptors comprise a unique family of proteins that have been implicated in the
pathophysiology and treatment of many central nervous system disorders, consistent with …

Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease

WH Ma, AF Chen, XY Xie, YS Huang - Neuropharmacology, 2021 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease and characterized
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …